ATE161885T1 - Expression der bindenden untereinheit des choleratoxins mit hilfe von fremden promotoren und/oder leadersequenzen - Google Patents

Expression der bindenden untereinheit des choleratoxins mit hilfe von fremden promotoren und/oder leadersequenzen

Info

Publication number
ATE161885T1
ATE161885T1 AT89850295T AT89850295T ATE161885T1 AT E161885 T1 ATE161885 T1 AT E161885T1 AT 89850295 T AT89850295 T AT 89850295T AT 89850295 T AT89850295 T AT 89850295T AT E161885 T1 ATE161885 T1 AT E161885T1
Authority
AT
Austria
Prior art keywords
expression
binding subunit
cholerate
oxine
foreign
Prior art date
Application number
AT89850295T
Other languages
English (en)
Inventor
Jan Holmgren
Castillo Joaquin Sanches
Original Assignee
Vitec Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitec Aktiebolag filed Critical Vitec Aktiebolag
Application granted granted Critical
Publication of ATE161885T1 publication Critical patent/ATE161885T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
AT89850295T 1988-09-16 1989-09-11 Expression der bindenden untereinheit des choleratoxins mit hilfe von fremden promotoren und/oder leadersequenzen ATE161885T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803291A SE462285B (sv) 1988-09-16 1988-09-16 Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer

Publications (1)

Publication Number Publication Date
ATE161885T1 true ATE161885T1 (de) 1998-01-15

Family

ID=20373364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89850295T ATE161885T1 (de) 1988-09-16 1989-09-11 Expression der bindenden untereinheit des choleratoxins mit hilfe von fremden promotoren und/oder leadersequenzen

Country Status (13)

Country Link
EP (1) EP0368819B1 (de)
JP (1) JP2790333B2 (de)
AT (1) ATE161885T1 (de)
AU (1) AU633842B2 (de)
CA (1) CA1340577C (de)
DE (1) DE68928529T2 (de)
DK (1) DK175694B1 (de)
ES (1) ES2113342T3 (de)
FI (1) FI104496B (de)
GR (1) GR3025846T3 (de)
IS (1) IS1804B (de)
NO (1) NO301175B1 (de)
SE (1) SE462285B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03187383A (ja) * 1989-09-04 1991-08-15 Takeda Chem Ind Ltd 発現プラスミドおよびその用途
US5356797A (en) * 1991-11-15 1994-10-18 Board Of Regents, The University Of Texas Membrane expression of heterologous genes
AU3130893A (en) * 1991-11-15 1993-06-15 Board Of Regents, The University Of Texas System Membrane expression of heterologous genes
US5932714A (en) * 1995-02-23 1999-08-03 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of Bordetella
US5998168A (en) * 1995-06-07 1999-12-07 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of bordetella
US6008329A (en) * 1998-03-06 1999-12-28 The United States Of America As Represented By The Secretary Of The Army Method for purifying cholera toxin
WO2007117339A2 (en) * 2006-01-11 2007-10-18 The United States Of America As Respresented By The Secretary Of The Navy Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli
DE102011111688A1 (de) * 2011-08-24 2013-02-28 Bioserv Analytik Und Medizinprodukte Gmbh Verfahren zur schnellen Isolation bzw. Aufreinigung von rekombinanten Proteinen mit einer (nicht toxischen) Choleratoxin-Domäne
CN109096403B (zh) * 2018-07-04 2020-06-30 浙江工商大学 一种用于蛋白质转导的蛋白质载体及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666837A (en) * 1982-05-24 1987-05-19 Smithkline-Rit DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants
EP0251579A3 (de) * 1986-06-24 1989-03-22 Enterovax Research Pty. Ltd. Markiersystem ohne Antibiotika
EP0358692B1 (de) * 1987-04-29 1998-06-03 President And Fellows Of Harvard College Impfstoff gegen cholera

Also Published As

Publication number Publication date
JP2790333B2 (ja) 1998-08-27
IS1804B (is) 2002-02-26
AU633842B2 (en) 1993-02-11
NO301175B1 (no) 1997-09-22
CA1340577C (en) 1999-06-01
FI894368A0 (fi) 1989-09-15
FI104496B (fi) 2000-02-15
DK456989A (da) 1990-03-17
DE68928529T2 (de) 1998-04-16
IS3505A7 (is) 1990-03-17
DE68928529D1 (de) 1998-02-12
GR3025846T3 (en) 1998-04-30
EP0368819A1 (de) 1990-05-16
AU4134989A (en) 1990-04-05
JPH0322997A (ja) 1991-01-31
FI894368L (fi) 1990-03-17
EP0368819B1 (de) 1998-01-07
DK456989D0 (da) 1989-09-15
NO893702D0 (no) 1989-09-15
SE462285B (sv) 1990-05-28
ES2113342T3 (es) 1998-05-01
NO893702L (no) 1990-03-19
DK175694B1 (da) 2005-01-24
SE8803291D0 (sv) 1988-09-16

Similar Documents

Publication Publication Date Title
AU573523B2 (en) Functional human urokinase proteins
FI871144A0 (fi) Foerfarande foer framstaellning av proteinprodukter i aspegillus oryzae och en promotor foer anvaendning i aspergillus.
EP0396612A4 (en) Novel plasmid vector with pectate lyase signal sequence
ATE160587T1 (de) Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung
ATE101203T1 (de) Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.
ATE161885T1 (de) Expression der bindenden untereinheit des choleratoxins mit hilfe von fremden promotoren und/oder leadersequenzen
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DE68923496D1 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
NO883611L (no) Ekspresjonsplasmider som inneholder deo-promotere, og bakterielle verter som inneholder disse plasmidene.
JPS6486876A (en) Variant human lysozyme
SE8800981D0 (sv) A recombinant fusion protein, its use and a recombinant vector

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time